← Back to Influence Map
Entity DossierOrganization
CAREFIRST BLUECROSS BLUESHIELD
DC · US
Health Insurance
Tracked direct giving
$0
Tracked donations to candidate
$0
LDA reported lobbying spend
$466,187
Connections
6
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$300KINSInsurance
$166KLobbying Firms Retained
RED+BLUE STRATEGIES$300K
CAREFIRST BLUECROSS BLUESHIELD$166K
Bills Referenced in Lobbying Filings
PBM
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Employed by | RED+BLUE STRATEGIES | Hired RED+BLUE STRATEGIES to lobby on Insurance / Health Plans | Source |
| commented_on | Department of Health and Human Services | Public comment on HHS-ONC-2023-0007: Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing | Source |
| commented_on | Centers for Medicare & Medicaid Services | Public comment on CMS-2024-0311: Patient Protection and Affordable Care Act: Notice of Benefit and Payment Parameters for 2026 and Basic Health Program | Source |
| Lobbied for | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $76,000 | Source |
| Lobbied for | Action to Delay Effective Date Consistent With Congressionally Enacted Moratorium | Lobbied on pbm — matched LDA filing topic to Federal Register rule. | Source |
| Lobbied for | Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure; Extension of Comment Period | Lobbied on pbm — matched LDA filing topic to Federal Register rule. | Source |